Oppenheimer Asset Management Inc. trimmed its position in Innospec Inc. (NASDAQ:IOSP – Free Report) by 7.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,396 shares of the specialty chemicals company’s stock after selling 1,538 shares during the quarter. Oppenheimer Asset Management Inc. owned about 0.07% of Innospec worth $2,025,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. raised its stake in shares of Innospec by 54.2% in the fourth quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company’s stock worth $136,000 after purchasing an additional 422 shares during the last quarter. KBC Group NV raised its position in Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock valued at $136,000 after acquiring an additional 558 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Innospec during the third quarter valued at approximately $215,000. Claro Advisors LLC purchased a new position in Innospec during the fourth quarter valued at approximately $220,000. Finally, Raymond James Trust N.A. raised its position in Innospec by 7.9% during the third quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company’s stock valued at $238,000 after acquiring an additional 155 shares in the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.
Innospec Price Performance
Innospec stock opened at $103.41 on Monday. The stock has a market capitalization of $2.58 billion, a PE ratio of 72.82 and a beta of 1.09. Innospec Inc. has a 12 month low of $99.49 and a 12 month high of $133.71. The business has a 50 day simple moving average of $110.06 and a 200-day simple moving average of $112.29.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Innospec from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th.
Read Our Latest Report on IOSP
Insider Activity
In other news, SVP Corbin Barnes sold 598 shares of Innospec stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $103.06, for a total value of $61,629.88. Following the sale, the senior vice president now directly owns 8,051 shares of the company’s stock, valued at $829,736.06. The trade was a 6.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Philip John Boon sold 3,754 shares of Innospec stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $387,788.20. Following the completion of the sale, the vice president now directly owns 20,079 shares in the company, valued at $2,074,160.70. This represents a 15.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,696 shares of company stock worth $794,853 over the last three months. 1.52% of the stock is currently owned by corporate insiders.
Innospec Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
- Five stocks we like better than Innospec
- How to Use the MarketBeat Excel Dividend Calculator
- Chaos and Cash: Finding Opportunity in Volatility
- What Investors Need to Know to Beat the Market
- Realty Income: An Anchor in Volatile Markets
- How to Calculate Return on Investment (ROI)
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.